Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (81-90 of 273) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|October 14, 2003
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell linesHiroaki Goto, Bo Yang, Denise Petersen, et al.
Human Gene Therapy|December 9, 2004
Factors influencing the titer and infectivity of lentiviral vectorsAaron C Logan, Sarah J Nightingale, Dennis L Haas, et al.
American Journal of Respiratory Cell and Molecular Biology|November 22, 2002
Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epitheliumJoanna E Grove, Carolyn Lutzko, Josef Priller, et al.
Pediatrics|October 4, 2005
Successful hematopoietic stem cell transplantation for Niemann-Pick disease type BAmi J Shah, Neena Kapoor, Gay M Crooks, et al.
Orphanet Journal of Rare Diseases|December 20, 2015
Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiencyHirsh D Komarow, Robert Sokolic, Michael S Hershfield, et al.
Gene Therapy|September 8, 2018
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilizationPeirong Hu, Yanmin Bi, Hong Ma, et al.
Human Gene Therapy|August 20, 2009
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemTeiko Sumiyoshi, Nathalia G Holt, Roger P Hollis, et al.
Molecular Therapy. Methods & Clinical Development|March 19, 2021
Gene delivery using AAV8 <i>in vivo</i> for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCIDDenise A Carbonaro-Sarracino, Krista Chun, Danielle N Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vectorHiroshi Kobayashi, Denise Carbonaro, Karen Pepper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replicationIngrid Bahner, Teiko Sumiyoshi, Mercy Kagoda, et al.
Pageof 28

Showing results (81-90 of 273) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|October 14, 2003
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell linesHiroaki Goto, Bo Yang, Denise Petersen, et al.
Human Gene Therapy|December 9, 2004
Factors influencing the titer and infectivity of lentiviral vectorsAaron C Logan, Sarah J Nightingale, Dennis L Haas, et al.
American Journal of Respiratory Cell and Molecular Biology|November 22, 2002
Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epitheliumJoanna E Grove, Carolyn Lutzko, Josef Priller, et al.
Pediatrics|October 4, 2005
Successful hematopoietic stem cell transplantation for Niemann-Pick disease type BAmi J Shah, Neena Kapoor, Gay M Crooks, et al.
Orphanet Journal of Rare Diseases|December 20, 2015
Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiencyHirsh D Komarow, Robert Sokolic, Michael S Hershfield, et al.
Gene Therapy|September 8, 2018
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilizationPeirong Hu, Yanmin Bi, Hong Ma, et al.
Human Gene Therapy|August 20, 2009
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemTeiko Sumiyoshi, Nathalia G Holt, Roger P Hollis, et al.
Molecular Therapy. Methods & Clinical Development|March 19, 2021
Gene delivery using AAV8 <i>in vivo</i> for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCIDDenise A Carbonaro-Sarracino, Krista Chun, Danielle N Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vectorHiroshi Kobayashi, Denise Carbonaro, Karen Pepper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replicationIngrid Bahner, Teiko Sumiyoshi, Mercy Kagoda, et al.
Pageof 28